BIIB
37
4
NFLX
58
-4
BRK.B
50
-6
AON
38
15
AVB
67
3
WEC
33
2
PEG
48
2
DVN
44
-3
RCL
66
-3
AES
55
15
MHK
36
-4
VIX
54
5
JCI
47
-2
DHR
50
-2
HPQ
63
6
HES
66
3
NKE
42
2
HON
58
-4
MUR
52
2
ZTS
25
2
BIIB
37
4
NFLX
58
-4
BRK.B
50
-6
AON
38
15
AVB
67
3
WEC
33
2
PEG
48
2
DVN
44
-3
RCL
66
-3
AES
55
15
MHK
36
-4
VIX
54
5
JCI
47
-2
DHR
50
-2
HPQ
63
6
HES
66
3
NKE
42
2
HON
58
-4
MUR
52
2
ZTS
25
2
Financhill
Back

Hikma Pharmaceuticals PLC 10K Form

Sell
35

HKMPF
Hikma Pharmaceuticals PLC

Last Price:
22.33
Seasonality Move:
0.88%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive HKMPF News And Ratings

See the #1 stock for the next 7 days that we like better than HKMPF

HKMPF Financial Statistics

Sales & Book Value

Annual Sales: $2.88B
Cash Flow: $0
Price / Cash Flow: 9.32
Annual Sales: $9.94
Price / Book: 2.25

Profitability

EPS (TTM): 0.85000
Net Income (TTM): $190M
Gross Margin: $1.39B
Return on Equity: 8.69%
Return on Assets: 4.14%

Hikma Pharmaceuticals PLC Earnings Forecast

Key Hikma Pharmaceuticals PLC Financial Ratios

  • The Gross Profit Margin over the past 22 years for HKMPF is 48.35%.
  • The Selling, General & Administrative Expenses for HKMPF have been equal to 22.19% of Gross Profit Margin.
  • The Research & Development expenses have been 5.18% of Revenue.
  • The Interest Expense is 38.42% of Operating Income.
  • The Net Earning history of HKMPF is 6.61% of Total Revenues.
  • Per Share Earnings over the last 22 years have been positive in 13 years.

Hikma Pharmaceuticals PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: HKMPF
Website: hikma.com

Debt

Debt-to-Equity Ratio: 0.51
Current Ratio: 1.57
Quick Ratio: 0.82

Price-to-Earnings

Trailing P/E Ratio: 26.27
Forward P/E Ratio: 0

HKMPF Technical Analysis vs Fundamental Analysis

Sell
35
Hikma Pharmaceuticals PLC (HKMPF) is a Sell

Is Hikma Pharmaceuticals PLC a Buy or a Sell?